SH2B3 and myeloproliferative disorder: Somatic mutations in SH2B3 gene have been described in myeloproliferative neoplasms [19], while germline SH2B3 pathogenic variants have been reported in myelodysplastic syndromes and acute lymphoblastic leukemia [20, 21].